(Q33399130)

26 July 2017

Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. (English)

1 reference

26 July 2017

Sibylle von Vietinghoff

7

object named as

Sibylle von Vietinghoff

1 reference

26 July 2017

6

Hermann Haller

1 reference

26 July 2017

Shuwang Ge

1

1 reference

26 July 2017

Barbara Hertel

2

1 reference

26 July 2017

Sang Hi Emden

3

1 reference

26 July 2017

Jan Beneke

4

1 reference

26 July 2017

Jan Menne

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

10 January 2012

1 reference

Nephrology Dialysis Transplantation

26 July 2017

1 reference

26 July 2017

27

1 reference

26 July 2017

7

1 reference

26 July 2017

2768-2775

1 reference

Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?

26 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Complement regulatory genes and hemolytic uremic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

β2-Integrins and Acquired Glycoprotein IIb/IIIa (GPIIb/IIIa) Receptors Cooperate in NF-κB Activation of Human Neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Induction of apoptosis by Shiga toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Interactions between Shiga toxins and human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Bcl-2 regulates the onset of shiga toxin 1-induced apoptosis in THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Eculizumab for congenital atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Eculizumab in severe Shiga-toxin-associated HUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Mechanisms of microparticle generation: on the trail of the mitochondrion!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR748

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR748

1 reference

26 July 2017

1 reference